Europe Biopharmaceuticals Market Report 2016

1 Biopharmaceuticals Overview 1

1.1 Product Overview and Scope of Biopharmaceuticals 1

1.2 Classification of Biopharmaceuticals 1

1.2.1 Monoclonal Antibodies 3

1.2.2 Interferon 4

1.2.3 Colony-Stimulating Factor 4

1.2.4 Erythropoietin 5

1.2.5 Insulin 6

1.2.6 Vaccines 7

1.2.7 Growth Hormones 7

1.3 Applications of Biopharmaceuticals 8

1.4 Biopharmaceuticals Market by Countries 10

1.4.1 Germany Status and Prospect (2011-2021) 10

1.4.2 France Status and Prospect (2011-2021) 11

1.4.3 UK Status and Prospect (2011-2021) 12

1.4.4 Russia Status and Prospect (2011-2021) 12

1.4.5 Italy Status and Prospect (2011-2021) 13

1.4.6 Benelux Status and Prospect (2011-2021) 14

1.4.7 Spain Status and Prospect (2011-2021) 14

1.5 Europe Market Size of Biopharmaceuticals (2011-2021) 15

1.5.1 Europe Biopharmaceuticals Sales and Growth Rate (2011-2021) 15

1.5.2 Europe Biopharmaceuticals Revenue and Growth Rate (2011-2021) 16

11 Biopharmaceuticals Manufacturing Cost Analysis 17

11.1 Biopharmaceuticals R&D Cost Analysis 17

11.1.1Clinical Phase Costs 18

11.1.2 Capitalized Costs 20

11.2 Proportion of Manufacturing Cost Structure 21

11.2.1 Raw Materials 21

11.2.2 Labor Cost 22

11.2.2.1 USA Labor Cost Analysis 22

11.2.2.2 Europe Labor Costs Analysis 25

11.2.2.3 Asia Labor Costs Analysis 27

11.2.3 Manufacturing Expenses 29

11.3 Manufacturing Process Analysis of Biopharmaceuticals 30

13 Marketing Strategy Analysis, Distributors/Traders 33

13.1 Marketing Channel 33

13.1.1 Direct Marketing 34

13.1.2 Indirect Marketing 34

13.1.3 Marketing Channel Development Trend 34

13.2 Market Positioning 35

13.2.1 Pricing Strategy 35

13.2.2 Brand Strategy 36

13.2.2.1 Introducing pharmaceutical branding strategies 36

13.2.2.2 Building pharmaceutical brands 37

13.2.2.3 Communicating pharmaceutical brands 38

13.2.2.4 Alternative brand models 39

13.2.2.5 The future of pharmaceutical branding 40

13.2.3 Target Client 41

13.3 Distributors/Traders List 44

14 Europe Biopharmaceuticals Market Forecast (2016-2021) 46

14.1 Germany Biopharmaceuticals Sales Forecast (2016-2021) 46

14.2 UK Biopharmaceuticals Sales Forecast (2016-2021) 48

14.3 France Biopharmaceuticals Sales Forecast (2016-2021) 50

14.4 Russia Biopharmaceuticals Sales Forecast (2016-2021) 52

14.5 Benelux Biopharmaceuticals Sales Forecast (2016-2021) 54

14.6 Italy Biopharmaceuticals Sales Forecast (2016-2021) 56

14.7 Spain Biopharmaceuticals Sales Forecast (2016-2021) 58

14.8 Europe Biopharmaceuticals Sales Forecast by Type (2016-2021) 59

14.9 Europe Biopharmaceuticals Sales Forecast by Application (2016-2021) 60

16 Appendix 61

Disclosure Section 61

Research Methodology 61

Data Source 63

Disclaimer 63

Figure Picture of Biopharmaceuticals 1

Table Classification of Biopharmaceuticals 1

Figure Europe Sales Market Share of Biopharmaceuticals by Types in 2015 3

Figure Monoclonal Antibodies Picture 4

Figure Interferon Picture 4

Figure Colony-Stimulating Factor Picture 5

Figure Erythropoietin Picture 6

Figure Insulin Picture 6

Figure Vaccines Picture 7

Figure Growth Hormones 8

Table Applications of Biopharmaceuticals 8

Figure Europe Sales Market Share of Biopharmaceuticals by Applications in 2015 9

Figure Germany Biopharmaceuticals Revenue (B USD) and Growth Rate (2011-2021) 10

Figure France Biopharmaceuticals Revenue (B USD) and Growth Rate (2011-2021) 11

Figure UK Biopharmaceuticals Revenue and Growth Rate (2011-2021) 12

Figure Russia Biopharmaceuticals Revenue and Growth Rate (2011-2021) 12

Figure Italy Biopharmaceuticals Revenue and Growth Rate (2011-2021) 13

Figure Benelux Biopharmaceuticals Revenue and Growth Rate (2011-2021) 14

Figure Spain Biopharmaceuticals Revenue and Growth Rate (2011-2021) 14

Figure Europe Biopharmaceuticals Sales (B USD) and Growth Rate (2011-2021) 15

Figure Europe Biopharmaceuticals Revenue (M USD) and Growth Rate (2011-2021) 16

Figure typical phases from research to the market for a drug candidate 18

Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 19

Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 20

Figure Manufacturing Cost Structure of Biopharmaceuticals 21

Figure Assessment of API Mannufacturing Cost By Region 22

Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour) 23

Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 23

Figure Cost of Employing a Factory Worker 25

Figure 2015 Estimated Labour Costs for the Whole Economy in EuropeR 26

Figure Monthly Minimum Wages in Asia 2016 27

Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year) 28

Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month) 28

Table 2015 Global Electricity Price of Industry (USD/KW·h) by Country 29

Figure Manufacturing Process Analysis of Biopharmaceuticals 30

Figure Production Flow Chart of Mammalian Cell Expression System Producing Line 31

Figure Production Flow Chart of Bacterial cell expression system Producing Line 31

Figure Biopharmaceuticals Marketing Process 32

Figure Marketing Channel for Biopharmaceuticals 33

Table Some of Famous Hospital 41

Table Distributors/Traders List 44

Figure Germany Biopharmaceuticals Sales and Growth Rate Forecast (2016-2021) 46

Figure Germany Biopharmaceuticals Revenue (B USD) and Growth Rate Forecast (2016-2021) 47

Figure UK Biopharmaceuticals Sales (B USD) and Growth Rate Forecast (2016-2021) 48

Figure UK Biopharmaceuticals Revenue (B USD) and Growth Rate Forecast (2016-2021) 49

Figure France Biopharmaceuticals Sales (B USD) and Growth Rate Forecast (2016-2021) 50

Figure France Biopharmaceuticals Revenue (B USD) and Growth Rate Forecast (2016-2021) 51

Figure Russia Biopharmaceuticals Sales (B USD) and Growth Rate Forecast (2016-2021) 52

Figure Russia Biopharmaceuticals Revenue (B USD) and Growth Rate Forecast (2016-2021) 53

Figure Benelux Biopharmaceuticals Sales (B USD) and Growth Rate Forecast (2016-2021) 54

Figure Benelux Biopharmaceuticals Revenue (B USD) and Growth Rate Forecast (2016-2021) 55

Figure Italy Biopharmaceuticals Sales (B USD) and Growth Rate Forecast (2016-2021) 56

Figure Italy Biopharmaceuticals Revenue (B USD) and Growth Rate Forecast (2016-2021) 57

Figure Spain Biopharmaceuticals Sales (B USD) and Growth Rate Forecast (2016-2021) 58

Figure Spain Biopharmaceuticals Revenue (B USD) and Growth Rate Forecast (2016-2021) 59

Table Europe Biopharmaceuticals Sales (B USD) Forecast by Type (2016-2021) 59

Table Europe Biopharmaceuticals Sales (B USD) Forecast by Application (2016-2021) 60